Inicio › Enfermedad pulmonar intersticial › Ohio
Ensayos clínicos de Enfermedad pulmonar intersticial en Ohio
14 estudios sobre Enfermedad pulmonar intersticial buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Cincinnati Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine, Cincinnati
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 29 sept 2026 · NCT05798923Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA015, Cincinnati
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07179380FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University Hospitals Cleveland Medical Center, Cleveland
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07540988A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Cincinnati
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Cincinnati Medical Center, Cincinnati
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University Hospitals Cleveland Medical Center, Cleveland
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Cincinnati Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- The Cleveland Clinic, Cleveland
- y 1 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 ago 2026 · NCT06388421Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Cleveland Clinic, Cleveland
- The Ohio State University, Columbus
ReclutandoEstudio observacional
Edades de 21 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Ohio State University, Columbus
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 10 ago 2026 · NCT07175038Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 2
Edades de 4 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Cincinnati Medical Center, Cincinnati
- St. Luke's Univeristy Health Network-Pulmonary & Critical Care, Cincinnati
- The Ohio State University Wexner Medical CEnter, Columbus
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 jul 2026 · NCT05943535A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- GSK Investigational Site, Columbus
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 22 jun 2026 · NCT06576271TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoEstudio observacional
Hasta los 24 · Todos los sexos · Actualizado el 22 jun 2026 · NCT04098445Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Cleveland
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 may 2025 · NCT05892614De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.